DIRS.INFO The most relevant business & tech news

☆ Is abortion rights your top issue? Here's a guide to each 2024 candidate's stance.
▼ + stars: | 2024-06-03 | by ( Brent D. Griffiths | ) www.businessinsider.com time to read: +6 min

Two years later, abortion rights remain a major issue in the 2024 election. Vice President Kamala Harris has taken the lead in the Biden campaign's push to highlight abortion rights on the campaign trail. The Senate filibuster requires a de facto 60-vote majority for legislation that would enshrine nationwide abortion rights protection into law. AdvertisementSome legal experts have also questioned whether Congress has the power to guarantee abortion access. Project 2025, an unofficial partnership of right-wing think tanks, has outlined an ambitious series of plans to curtail abortion rights if Trump wins in November.

Persons: —, Roe, Wade, Joe Biden's, Biden, Donald Trump, There's, Trump, Here's, Kamala Harris, Saul Loeb, Joe Biden, It's, reimbursing, Mark Wilson, Arizona, Katie Hobbs, hasn't Organizations: Service, Business, CBS, New York Times, Trump, Biden, Getty, Senate, GOP, Supreme, Pentagon, Republican, Justice Department, Republicans, Gov Locations: Arizona, Arizonans, Siena, mifepristone, Florida

☆ Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
▼ + stars: | 2024-06-03 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. The vaccine together with Merck's Keytruda improved survival and showed long-lasting efficacy in a midstage study in patients with a deadly form of skin cancer. Melanoma is responsible for the large majority of skin cancer deaths, according to the American Cancer Society. Moderna is also conducting another phase three trial of the vaccine in patients with a type of lung cancer. This year, Merck and Moderna started a two-part mid- to late-stage trial on the vaccine and Keytruda in patients at an advanced stage of a common skin cancer.

Persons: Merck's, Kyle Holen, Keytruda, Stephane Bancel, Bancel Organizations: Moderna, Merck, American Society of Clinical Oncology, CNBC, U.S . Food, Drug Administration, FDA, American Cancer Society Locations: Chicago, U.S, Moderna

☆ Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says
▼ + stars: | 2024-06-02 | by ( George Glover | ) www.businessinsider.com time to read: +1 min

The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs said. New products such as Eli Lilly's Zepbound prompted the bank to raise its forecast. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . AdvertisementThe market for weight-loss drugs such as Ozempic and Wegovy will keep surging due to new products including Eli Lilly's Zepbound, according to Goldman Sachs. In a research note the bank forecast that the sector will be worth $130 billion by 2030 — $30 billion higher than its previous projection.

Persons: Goldman Sachs, Eli Lilly's Zepbound, —, Wegovy, Eli Lilly, Chris Shibutani Organizations: FDA, pharma, Service, Nordisk, Business Locations: Danish

☆ Here’s what to expect as the Supreme Court enters the final stretch
▼ + stars: | 2024-06-02 | by ( John Fritze | ) edition.cnn.com time to read: +9 min

CNN —The Supreme Court is turning toward the final, frenzied weeks of its term, readying potential blockbuster decisions on abortion, guns and former President Donald Trump’s claims of absolute immunity. Trump claims ‘absolute’ immunityTrump’s appeal for immunity from special counsel Jack Smith’s election subversion charges landed at the Supreme Court late in the term and instantly overshadowed most of the docket. The Supreme Court then put that ruling on hold last year, maintaining the status quo while it decided the case. Government regulation of FacebookThe Supreme Court is confronting a series of cases at the intersection of the First Amendment and social media. The Republican governors who signed the laws said they were needed to keep the social media platforms from discriminating against conservatives.

Persons: Donald Trump’s, –, Roe, Samuel Alito, Trump, Jack Smith’s, Biden, Wade, Matthew Kacsmaryk, Kacsmaryk, Joseph Fischer, ”, Joe Biden’s, Zackey Rahimi, Bruen, Moody, Washington, Raimondo Organizations: CNN, Wade, Conservative, Supreme, White, Trump ., Food and Drug Administration, FDA, Alliance for Hippocratic, US, Pennsylvania, Capitol, Trump, Prosecutors, New York, Rahimi, Facebook, Florida, Biden, Republican, Atlantic, of Commerce, Chevron, Natural Resources Defense, Conservatives, Bright Enterprises, . Department of Commerce Locations: Virginia, New Jersey, Washington, Idaho, Moyle v, Amarillo , Texas, ”, Texas, New, Louisiana, Florida, Atlanta, New Orleans, Paxton, – Missouri, . Missouri

☆ FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
▼ + stars: | 2024-05-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

The Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial virus for adults ages 60 and above, the company's second-ever product to enter the U.S. market. The approval of Moderna's shot is based on a late-stage trial on older adults, who are more vulnerable to severe cases of RSV. The company's shot is also the only RSV vaccine to be available in a pre-filled syringe, which is designed to make it easier to administer to patients. An advisory panel to the CDC will vote in June on recommendations for the use and intended population of Moderna's shot. Moderna's full-year 2024 sales guidance of roughly $4 billion includes revenue from its RSV vaccine.

Persons: Moderna's, Stéphane Bancel Organizations: Drug Administration, Moderna, Centers for Disease Control, CDC, GSK, Pfizer Locations: U.S

☆ Former FDA Commissioner Dr. Scott Gottlieb on the rise of synthetic nicotine
▼ + stars: | 2024-05-30 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA Commissioner Dr. Scott Gottlieb on the rise of synthetic nicotineFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the rise of synthetic nicotine, the risks and regulation of products that use nicotine-like chemicals, avian-flu concerns, and more.

Persons: Scott Gottlieb Organizations: Former

☆ Why replacing alcohol with weed is a growing trend in the US
▼ + stars: | 2024-05-30 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +11 min

The use of weed to replace alcohol is a growing trend in the United States. “We know that moderate alcohol consumption has health risks, and risk increases as alcohol consumption increases,” Boyd said in an email. “Cannabis smoke contains toxins, carcinogens, and particulate matter that have been linked to cancer, lung damage, and cardiovascular disease,” Cohen said in an email. Research on edibles, such as baked goods, candies and beverages, and other methods of using cannabis is in its infancy. “In and of itself, it’s not good that more people are using cannabis,” Grinspoon said.

Persons: CNN —, “, —, ”, “ I’ve, Carol Boyd, ” Boyd, Weed, Peter Grinspoon, ” “, ” Grinspoon, Beth Cohen, ” Cohen, I’m, Boyd, ” Robert Page II, Grinspoon, ideation, it’s Organizations: CNN, National Survey, Center, Drugs, University of Michigan, US Centers for Disease Control, Massachusetts General Hospital, Marijuana, University of California, University of Colorado Skaggs School of Pharmacy, Pharmaceutical Sciences, Drug, Food and Drug Administration, National Poison Center, FDA, Lifeline Locations: United States, Washington, Ann Arbor, Boston, San Francisco, Aurora, Georgia

A small group of stocks are on the verge of forming a worrisome chart pattern known as a "death cross ." A death cross occurs when a stock's 50-day moving average falls below its 200-day average. Baxter International Stock in medical equipment maker Baxter International is also on the verge of a death cross. Other stocks nearing a death cross chart pattern include Illinois Tool Works and Abbott Laboratories . While the golden cross suggests a potential uptrend, ITW is now approaching the bearish death cross chart pattern only five months later.

Persons: Goldman Sachs, Bonnie Herzog, Clorox, TD Cowen, Joshua Jennings, Baxter, Jennings, Abbott's Organizations: Nasdaq, CNBC, Baxter International Stock, Baxter, Abbott Laboratories ., Tool, Abbott Laboratories, U.S . Food, Drug Administration Locations: Hillrom, Illinois, U.S

☆ AI cancer screening programs are booming, but you'll likely have to pay for them yourself
▼ + stars: | 2024-05-30 | by ( Bertha Coombs | ) www.cnbc.com time to read: +6 min

watch nowArtificial intelligence for cancer screening has taken off. So, it is quite a challenge," said Brittany Berry-Pusey, CEO of AI screening startup Avenda Health. Nearly 600 of them have been radiology AI applications approved in the last five years. Thorwarth wrote that AI reimbursement is complex and establishing billing codes for every approved AI tool is "problematic." RadNet's executives compare the process with AI screening to the radiology industry's experience with digital breast Tomosynthesis, known as 3D mammography.

Persons: Brittany Berry, Pusey, Porte, Julien De Rosa, Berry, William Thorwarth, Thorwarth, mammography, Rodrigo Cerda, Cerda, RadNet, Greg Sorensen, RadNet's, Sorensen Organizations: FDA, Food and Drug Administration, Porte de, Afp, Getty, American Medical Association, American College of Radiology, Centers, Medicare, Medicaid Services, CNBC, Artificial Intelligence, Blue Cross Locations: Paris, New Jersey

☆ Wells Fargo CEO talks up reasons to love the stock — plus, what's behind the market drop
▼ + stars: | 2024-05-29 | by ( Zev Fima | ) www.cnbc.com time to read: +5 min

Apple and Nvidia, our two "own, don't trade" stocks were also the top performers among the entire 33 stock Club portfolio. When the Federal Reserve at some point removes its asset cap on Wells Fargo, Scharf said corporate lending and trading will be areas of growth for the bank. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Hess, Merck, Morgan Chittum, Charlie Scharf, Scharf, Wells, Wells Fargo's, " Scharf, it's, Wells Fargo, Eli Lilly, CNBC's David Faber, Locker, Jim Cramer's, Jim Organizations: CNBC, Dow, Nvidia, American Airlines, Tech, Apple, Microsoft, ConocoPhillips, Chevron, Banking, Investing Club, Wells, Bernstein's, Investment Banking, Wealth Management, Federal Reserve, FDA, Club, Costco, Broadcom, Jim Cramer's Charitable Locations: Wells Fargo

☆ Stocks making the biggest moves midday: GameStop, U.S. Cellular, Nvidia, Norwegian Cruise Line and more
▼ + stars: | 2024-05-28 | by ( Michelle Fox | ) www.cnbc.com time to read: +4 min

Check out the companies making the biggest moves midday: GameStop — Shares jumped nearly 23% following the video game retailer's announcement on Friday that it made about $933 million from a stock sale. U.S. Cellular — Shares added 7% after the telecom company announced T-Mobile will acquire its wireless operations and 30% of spectrum assets for $4.4 billion. T-Mobile was up less than 1%, while Telephone and Data Systems , which owns 84% of U.S. Cellular, slipped 2%. Norwegian Cruise Line — The cruise stock rose 3% after an upgrade to buy from neutral at Mizuho. Zscaler — The cybersecurity company shed nearly 4% following a downgrade at Wells Fargo to equal weight from overweight.

Persons: Agios, vorasidenib, —, Duolingo Max, Semler, Elon, Zscaler, Airbnb, Eli Lilly, Macheel, Pia Singh, Hakyung Kim, Jesse Pound Organizations: GameStop, . Illinois, U.S, Cellular, Mobile, Telephone, Data Systems, U.S . Cellular, . Food, Drug, Pharmaceuticals, Royalty Pharma, Nvidia, Cruise, Mizuho, Sarepta Therapeutics, RBC Capital Markets, RBC, Sea, Reuters, —, Energy Capital Partners, Wedbush, FDA Locations: U.S, Norwegian, Wells

In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly's highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. VanGilder signed up nearly four years ago and started taking the weekly diabetes injection Ozempic specifically for weight loss. The big difference between Calibrate and prior weight loss efforts, VanGilder said, is that she doesn't feel like she's dieting. Calibrate is one of the only companies to regularly release reports detailing the results of its weight loss program. The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health.

Persons: Michael Siluk, Gray Beard, She'd, that's, Beard, wouldn't, She's, Ro, Goldman Sachs, Eli Lilly's, it's, Andrew Dudum, There's, Zachariah Reitano, Reitano, Wegovy, WeightWatchers, Gary Foster, Foster, Oprah Winfrey's, Kim Gradwell, Lee Smith, Jennifer VanGilder, she'd, Jenny Craig, VanGilder, I've, Kristin Baier, Rob MacNaughton, Ro's Reitano, we'd, Eli Lilly, Craig Primack, Primack, Hims, Dudum, We're Organizations: — Novo, UCG, Novo Nordisk, CNBC, Teladoc Health, World Health Organization, Food, WeightWatchers Clinic, Ursinus College, Asset Management Locations: Charlotte , North Carolina, U.S, Dudley , North Tyneside, Britain, Collegeville , Pennsylvania, Hims

☆ Here's what it's like inside the operating room when someone gets a brain implant
▼ + stars: | 2024-05-25 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +11 min

Bederson, system chair for the Department of Neurosurgery at Mount Sinai Health System, is no stranger to long hours in an operating room. In fact, it marked the 14th time that the company has placed its array on a human patient's brain. Four of Precision's arrays were carefully laid out on a table nearby. Using a pair of yellow tweezers called long bayonet forceps, Bederson began placing all four of Precision's electrode arrays onto the patient's brain. Real-time renderings of the patient's brain activity swept across Precision's monitors in the operating room.

Persons: Joshua Bederson, Ashley Capoot, Bederson, Elon Musk, Stephanie Rider, Ignacio Saez, Saez, Bederson's, Benjamin Rapoport, Precision's, Ashley Capoot Bederson, Precision's Rapoport, Rapoport, Ashley Capoot Rapoport, Thomas Oxley, Synchron Organizations: Sinai, Neurosurgery, Sinai Health, CNBC, Neuroscience, BCI, Tesla, SpaceX, Icahn School of Medicine, U.S . Food, Drug Administration, Mount, Mount Sinai, Precision Neuroscience, Weill Cornell Medicine, Wall Locations: New York City, Mount Sinai, U.S, Mount, Synchron

☆ Here's how U.S. health officials are responding to bird flu in humans after second case
▼ + stars: | 2024-05-24 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +7 min

Brandon Bell | Getty ImagesU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress that the risk to the general public remains low. An Australian child was also recently infected with bird flu, the country announced on Tuesday. In rare cases, bird flu viruses spread to humans and can cause mild to severe symptoms that can require hospitalization. The Food and Drug Administration would need to approve bird flu vaccines before they roll out. Potential mRNA shotsU.S. health officials are also in talks with messenger RNA vaccine makers about potential bird flu shots for humans.

Persons: Brandon Bell, Andrew Pekosz, Pekosz, Peter Chin, That's, Hong Organizations: Getty, Disease Control, U.S ., Human Services Department, CNBC, Johns Hopkins Bloomberg School of Public Health, CDC, HHS, NBC News, UCSF Health, Drug Administration, FDA, Pfizer, Moderna Locations: Quemado , Texas, Michigan, Australian, U.S

☆ Chemical toxin exposure in the womb linked to greater health risks for children ages 6 to 11
▼ + stars: | 2024-05-23 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +11 min

CNN —Chemical toxins are everywhere — in our water, food, air and soil. Children born to European mothers exposed to four families of chemicals that disrupt the body’s endocrine (hormone) system had elevated levels of metabolic syndrome at ages 6 to 11. Metabolic syndrome can include obesity, elevated blood pressure, and abnormally high cholesterol and insulin resistance, which is a precursor to type 2 diabetes. Metabolic syndrome is typically associated with adult cardiovascular disease, type 2 diabetes and stroke, but the growing epidemic of childhood obesity has seen symptoms appearing in kids at younger and younger ages. Having metabolic syndrome as a child is highly predictive of chronic disease as an adult, experts say.

Persons: Nuria Güil, ”, Oumrait, Vicente Mustieles, Mariana Fernández, Carmen Messerlian, Messerlian, phthalates, “, Jane Houlihan, ” Houlihan, Houlihan, PFAS, EWG Organizations: CNN, Icahn School of Medicine, JAMA, Biomedical Research, University of Granada, Harvard, of Public Health, International Council for Chemical Associations, American Chemistry Council, EPA, Food, Food and Drug Administration, FDA, NSF, National Sanitation Foundation Locations: Mount Sinai, New York City, Spain, Messerlian, Chan, Boston, United States

☆ This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
▼ + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com time to read: +7 min

RBC Capital Markets sees a $25 billion market opportunity for the space. The average analyst rating is hold, with 8% upside to the average analyst price target, according to FactSet. Eli Lilly has an average analyst rating of overweight and 8.3% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon AstraZeneca's one-year performanceAstraZeneca shares have an average analyst rating of overweight and nearly 6% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon Bristol-Myers Squibb's one-year performance

Persons: It's, Gregory Renza, Renza, Oppenheimer, Jeff Jones, Piper Sandler, Edward Tenthoff, Eli Lilly, Dan Lyons, Janus Henderson, Myers Squibb, William Blair, Matt Phipps, Jefferies, Andrew Tsai, They've, Janus Henderson's Lyons, Jones, Piper Sandler's Tenthoff, Myers Organizations: pharma, RBC Capital Markets, TRT, Novartis, Mariana Oncology, Janus, Janus Henderson Investors, Bristol, RayzeBio, Karuna Therapeutics, AstraZeneca, Fusion Pharmaceuticals, GlobalData's Pharma Intelligence, Pluvicto Locations: Mariana, Bristol

☆ Nestle announces Vital Pursuit frozen-food brand targeting GLP-1 users
▼ + stars: | 2024-05-22 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNestle announces Vital Pursuit frozen-food brand targeting GLP-1 usersFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Nestle's new frozen food brand, whether Americans should eat this food, and more.

Persons: Scott Gottlieb Organizations: Nestle, FDA

☆ Jamie Dimon might finally be ready to call it quits
▼ + stars: | 2024-05-21 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +7 min

The big storyA retirement loomsMarianne Ayala/BIThe world's most recognizable banker might finally be ready to call it quits. The comings and goings of Wall Street executives are common, even at the highest levels. Wall Street has long speculated about who will ultimately succeed Dimon. Martin Gruenberg has told staff he'll stand down as chairman once a replacement has been found , per The Wall Street Journal. A report from the Wall Street Journal says the company hopes to conduct its next implant in June.

Persons: —, Jamie Dimon's, Marianne Ayala, Jamie Dimon, Insider's Paul Squire, nodded, Morgan Stanley, JPMorgan's, Tom Williams, Dimon, Jennifer Piepszak, Marianne Lake, Troy Rohrbaugh, BI's Reed Alexander, Reed, M, Alyssa Powell, Goldman Sachs, Lindsay MacMillan, Nancy Lazar, Piper, Martin Gruenberg, OpenAI, Scarlett Johansson, Sam Altman's, Andrea Chronopoulos, they're, Dan DeFrancesco, Jordan Parker Erb, Hallam Bullock, George Glover Organizations: Service, Navy SEAL, Business, JPMorgan, Street, Citi, Bank, Inc, Getty, Wall, Dimon, Bank of America, FDIC, Microsoft, Wall Street Journal Locations: New York, London

☆ AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
▼ + stars: | 2024-05-21 | by ( Sophie Kiderlin | In | ) www.cnbc.com time to read: +2 min

Costfoto | Future Publishing | Getty ImagesLONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. AstraZeneca will focus on its oncology, biopharmaceuticals and rare diseases businesses and expects to release an additional 20 medicines in the next six years. "Many of them have the potential to be $5 billion drugs," Sarin noted. A company statement detailed that this revenue figure could be hit annually for many of the new medicines in peak years. "For the entire market to get replaced it will take time, but we think we have the technology today to start replacing them," Sarin told CNBC.

Persons: CNBC's Arabile Gumede Organizations: Astrazeneca, Artificial Intelligence, — Pharmaceutical, AstraZeneca, CNBC, U.S . FDA, Pharmaceuticals, Investments Locations: Shanghai, China, Europe, London, Singapore

☆ The 10 states where your pet is more likely to get sick from tick-borne diseases, viruses, parasites, and more
▼ + stars: | 2024-05-21 | by ( Ellyn Lapointe | ) www.businessinsider.com time to read: +6 min

AdvertisementHere are the 10 riskiest states for your pet, the most common diseases to watch out for, and some basic tips for keeping your pet happy and healthy. Top 10 riskiest states for your petForbes Advisor created its own ranking scale based on data from all 19 diseases. Two of these 10 states, West Virginia and Maine, were also among the top three riskiest states for tick-borne diseases. The most common diseases to watch out forTicksTick-borne diseases like Lyme Disease, anaplasmosis, and ehrlichiosis are especially common in the spring and summer months. Fever, lethargy, loss of appetite, and joint stiffness or pain are all common symptoms of these three tick-borne diseases.

Persons: —, Alexandria Cremer, Peter M, Fisher, It's Organizations: Service, Forbes, Business, Center for Disease Control, American Veterinary Medical Association, York, West Virginia, Veterinary Clinic, Watch, Cornell's College of Veterinary Medicine, American Society for, FDA, US, MetLife, Animal Foundation Locations: Jersey, Coast, Rhode, , New Jersey , Maine , New York, Pennsylvania, West Virginia, Maine, Arkansas, South Dakota , Wisconsin, New Mexico , Mississippi, Oklahoma, Kentucky, Mississippi, Brandywine

☆ Neuralink will embed wires deeper in the brain to fix problems after its first patient: WSJ
▼ + stars: | 2024-05-20 | by ( Geoff Weiss | ) www.businessinsider.com time to read: +1 min

Neuralink has gotten the FDA go-ahead for a second implant, the Wall Street Journal reports. This time, it's implanting the wires a few millimeters deeper to prevent retraction. Neuralink's first patient lost some function but has since greatly improved, the Journal reported. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . AdvertisementNeuralink has gotten the go-ahead to implant its device into a second patient — and has settled on a fix for the error that plagued its inaugural trial.

Persons: Neuralink, it's, Neuralink's, — Organizations: Wall Street, Service, Street, Food and Drug Administration, Business

Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and hair loss, launched a weight loss program in December. But GLP-1 medications — the class of drugs like Ozempic and Wegovy that have skyrocketed in popularity — were not previously offered as part of that program. Customers can access the compounded GLP-1 medications via a prescription from a licensed healthcare providers on the Hims & Hers platform. The company's oral medication kits start at $79 a month, and its compounded GLP-1 injections will start at $199 a month.

Persons: Andrew Dudum, Dudum Organizations: Novo Nordisk, FDA, U.S . Food, Drug Administration, CNBC, & $ Locations: U.S

☆ Insider Today: Google's big shakeup
▼ + stars: | 2024-05-19 | by ( Matt Turner | ) www.businessinsider.com time to read: +4 min

Sign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. If you're interviewing for a job in the coming weeks, check out these five questions to ask at the end. Roaring Kitty; Getty Images; Alyssa Powell/BIThis week's dispatchInvestors go back to the futureAdvertisementStocks hit record highs. And with bitcoin hovering near record highs and the crypto winter seemingly behind us, crypto companies are on the front foot once more. Erdinhasdemir/Getty Images, Choness/Getty Images, Abanti Chowdhury/BIThe hottest jobs right now are blueWant a six-figure salary?

Persons: —, Kitty, Alyssa Powell, Keith Gill, Brandon Celi, Abanti Chowdhury, Jobs, Richard A, Rick Doblin, Sundar Pichai Mateusz, Chelsea Jia Feng Google's, shakeup, Sundar Pichai, Pichai, Adam Selipsky's Organizations: Service, Business, Dow, Consumers, Walmart, UPS, FDA, Getty Images, Google, Amazon Locations: Ukraine, East, Silicon

☆ Step aside, Ozempic — Zyn is the new (delusional) weight-loss quick fix
▼ + stars: | 2024-05-17 | by ( Mia De Graaf | Hilary Brueck | ) www.businessinsider.com time to read: +8 min

Now, Zyn users are buzzing about another purported side effect: Some claim that their habit has triggered weight loss. Andrea Hernández, author of consumer trend newsletter Snaxshot, pointed out this craze this week, sharing a collection of social media posts about Zyn and weight loss. "I've used Zyn nicotine pouches occasionally over the past few years but have started to use them regularly because they help me focus and curb my hunger," a Reddit user wrote in r/intermittentfasting. While nicotine pouches circumvent the health effects of cigarettes that are caused by tobacco, they still do a number on your body. She worries that "we don't fully understand how nicotine works to regulate appetite in people, specifically with obesity."

Persons: —, Tucker Carlson, Carlson, Andrea Hernández, I've, Carolyn Bramante, Bramante, vapes, Slim, Apple AirPods, Philip Morris, Forget, I'm, Elon Musk, Charles Barkley, Hernández, Michael M, Beverly Tchang, Tchang, Iuliia Burmistrova Organizations: Service, Business, University of Minnesota, FDA, Lucky, Samsung, Getty, Weill, Philip Morris International, Swedish Locations: New York

☆ FDA approves Amgen's treatment for most deadly form of lung cancer
▼ + stars: | 2024-05-16 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

In clinical trials, Amgen's drug has been shown to reduce tumor growth and help people with small-cell lung cancer live significantly longer. Of the more than 2.2 million patients who are diagnosed with lung cancer worldwide each year, small-cell lung cancer comprises 15%, or 330,000, of those cases, Amgen said. There are around 35,000 patients with small-cell lung cancer in the U.S., Dr. Jay Bradner, Amgen's chief scientific officer, told CNBC. Small-cell lung cancer usually starts in the airways of the lung and grows rapidly, creating large tumors and spreading throughout the body. Maida Mangiameli, a small-cell lung cancer advocate and patient mentor from Naperville, Illinois, is also a survivor of the devastating disease.

Persons: Amgen, Jay Bradner, Bradner, Lynne Bell, Amgen's, Bell, I'm, Maida, Mangiameli, Amgen's Bradner Organizations: Drug Administration, of Cancer, CNBC, American Cancer Society Locations: U.S, Atlanta , Georgia, Naperville , Illinois

Search resuls for: "FDA"

25 mentions found